HK1165271A1 - Composition comprising vip or its active fragments for use in treating aortic fibrosis - Google Patents

Composition comprising vip or its active fragments for use in treating aortic fibrosis

Info

Publication number
HK1165271A1
HK1165271A1 HK12105842.5A HK12105842A HK1165271A1 HK 1165271 A1 HK1165271 A1 HK 1165271A1 HK 12105842 A HK12105842 A HK 12105842A HK 1165271 A1 HK1165271 A1 HK 1165271A1
Authority
HK
Hong Kong
Prior art keywords
vip
composition
active fragments
treating aortic
aortic fibrosis
Prior art date
Application number
HK12105842.5A
Other languages
English (en)
Chinese (zh)
Inventor
Karen Annette Duggan
Original Assignee
Vectus Biosystems Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901425A external-priority patent/AU2009901425A0/en
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of HK1165271A1 publication Critical patent/HK1165271A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK12105842.5A 2009-04-02 2012-06-14 Composition comprising vip or its active fragments for use in treating aortic fibrosis HK1165271A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009901425A AU2009901425A0 (en) 2009-04-02 Compositions and methods for treatment of aortic fibrosis
PCT/AU2010/000391 WO2010111753A1 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis

Publications (1)

Publication Number Publication Date
HK1165271A1 true HK1165271A1 (en) 2012-10-05

Family

ID=42827427

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105842.5A HK1165271A1 (en) 2009-04-02 2012-06-14 Composition comprising vip or its active fragments for use in treating aortic fibrosis

Country Status (19)

Country Link
US (2) US8729020B2 (ko)
EP (1) EP2413954B1 (ko)
JP (1) JP5687266B2 (ko)
KR (1) KR101627008B1 (ko)
CN (1) CN102711797A (ko)
AU (1) AU2010230862B2 (ko)
BR (1) BRPI1006748A2 (ko)
CA (1) CA2757076C (ko)
DK (1) DK2413954T3 (ko)
ES (1) ES2462501T3 (ko)
HK (1) HK1165271A1 (ko)
IL (1) IL215460A (ko)
MX (1) MX2011010341A (ko)
MY (1) MY180681A (ko)
NZ (1) NZ595726A (ko)
RU (1) RU2536223C2 (ko)
SG (1) SG174966A1 (ko)
WO (1) WO2010111753A1 (ko)
ZA (1) ZA201107820B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2783697T3 (en) * 2005-12-09 2017-04-10 Vectus Biosystems Ltd VIP Fragments and uses thereof
KR101671406B1 (ko) * 2008-10-17 2016-11-01 벡투스 바이오시스템즈 리미티드 신장 장애 치료용 조성물 및 방법
EP2990027A1 (en) * 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
CN104980999B (zh) * 2015-06-19 2017-03-08 广东欧珀移动通信有限公司 一种网络接入方法及移动终端

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514697A (ja) * 2000-11-28 2004-05-20 モンドバイオテック・ソシエテ・アノニム 肺及び細動脈高血圧症治療用の血管作動性腸管ペプチドの生物学的活性をもつ化合物
WO2005120545A1 (en) * 2004-06-11 2005-12-22 Vectus Biosystems Limited Compositions and methods for treatment of cardiovascular disease
DK2783697T3 (en) * 2005-12-09 2017-04-10 Vectus Biosystems Ltd VIP Fragments and uses thereof
WO2009033780A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
KR101671406B1 (ko) * 2008-10-17 2016-11-01 벡투스 바이오시스템즈 리미티드 신장 장애 치료용 조성물 및 방법

Also Published As

Publication number Publication date
JP2012522727A (ja) 2012-09-27
ZA201107820B (en) 2013-09-25
AU2010230862B2 (en) 2014-04-17
MX2011010341A (es) 2012-01-27
US20140235541A1 (en) 2014-08-21
CN102711797A (zh) 2012-10-03
IL215460A0 (en) 2011-12-29
ES2462501T3 (es) 2014-05-23
SG174966A1 (en) 2011-11-28
NZ595726A (en) 2013-06-28
CA2757076C (en) 2017-05-16
JP5687266B2 (ja) 2015-03-18
DK2413954T3 (da) 2014-05-12
BRPI1006748A2 (pt) 2018-03-06
KR101627008B1 (ko) 2016-06-02
CA2757076A1 (en) 2010-10-07
EP2413954A1 (en) 2012-02-08
US20120027850A1 (en) 2012-02-02
US8729020B2 (en) 2014-05-20
IL215460A (en) 2017-01-31
RU2536223C2 (ru) 2014-12-20
RU2011142268A (ru) 2013-05-10
EP2413954A4 (en) 2012-11-21
KR20120024572A (ko) 2012-03-14
EP2413954B1 (en) 2014-02-26
AU2010230862A1 (en) 2011-11-03
MY180681A (en) 2020-12-06
WO2010111753A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
HK1220631A1 (zh) 用於遞送治療劑的陰離子核心組合物以及製備和使用所述組合物的方法
GB2469580B (en) Delivery method and compositions
EP2473196A4 (en) ADMINISTRATION OF SDF-1 FOR THE TREATMENT OF ISCHEMIC FABRICS
IL215059A (en) Liposome preparation that includes an arboline and a process for its preparation
IL217774A0 (en) Compositions for treating gaucher disease and uses thereof
HK1165293A1 (en) Composition for the treatment of cystic fibrosis
IL215684A0 (en) Trehalulose-containing composition, its preparation and use
EP2292560A4 (en) TITANIUM OXIDE STRUCTURE AND POROUS TITANIUM OXIDE COMPOSITION
IL214500A0 (en) Compositions and methods for extended therapy with aminopyridines
EP2437755A4 (en) SURFACE COMPOSITION COMPOSITIONS AND METHODS FOR INCREASED OXYGENATION, REDUCED BACTERIA STOCKS AND IMPROVED WOUND HEALING
EP2416801A4 (en) IMMUNOGENIC COMPOSITION AND ITS USES
GB0903299D0 (en) Composition and methods
GB0912468D0 (en) Composition and method
IL217766A (en) Active compound with fragrance
EP2355836A4 (en) COMPOSITIONS AND METHODS FOR PROMOTING VASCULAR BARRIER FUNCTION AND TREATMENT OF PULMONARY FIBROSIS
GB0823497D0 (en) Immunogenic composition and use thereof
HK1165271A1 (en) Composition comprising vip or its active fragments for use in treating aortic fibrosis
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD
IL218726A (en) Pharmaceuticals for the treatment of Down syndrome
PL2263454T3 (pl) Kompozycja uzdatniająca
GB0901667D0 (en) Composition and method
ZA201206853B (en) Composition for use in water treatment
ZA201101088B (en) Cleaning composition and method
GB0901293D0 (en) Composition, method and use
GB0901234D0 (en) Composition,method and use